Synergistic anticancer effect of exogenous wild-type p53 gene combined with 5-FU in human colon cancer resistant to 5-FU in vivo

被引:15
|
作者
Xie, Qi [1 ]
Wu, Min-Yi [1 ]
Zhang, Ding-Xuan [1 ]
Yang, Yi-Ming [1 ]
Wang, Bao-Shuai [1 ]
Zhang, Jing [2 ]
Xu, Jin [3 ]
Zhong, Wei-De [4 ]
Hu, Jia-Ni [5 ]
机构
[1] Guangzhou Med Univ, Dept Med Imaging, Nansha Cent Hosp, Guangzhou Peoples Hosp 1, Guangzhou 511457, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Dept Pathol, Ctr Canc, Guangzhou 510080, Guangdong, Peoples R China
[3] Guangzhou Med Univ, Dept Pathol, Guangzhou Peoples Hosp 1, Guangzhou 510180, Guangdong, Peoples R China
[4] Guangzhou Med Univ, Clin Mol Med & Mol Diagnost Lab, Guangzhou Peoples Hosp 1, Guangzhou 510180, Guangdong, Peoples R China
[5] Wayne State Univ, Karmanos Canc Inst, Detroit, MI 48201 USA
关键词
Human colon cancer; Multidrug resistance; 5-Fluorouracil; Recombinant adenovirus-mediated p53; Xenografts in nude mice; TUMOR-SUPPRESSOR GENE; COLORECTAL-CANCER; MULTIDRUG-RESISTANCE; THYMIDYLATE SYNTHASE; DRUG-RESISTANCE; BREAST-CANCER; CELL-LINE; 5-FLUOROURACIL; THERAPY; CARCINOMA;
D O I
10.3748/wjg.v22.i32.7342
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM To investigate the anticancer effect of a recom-binant adenovirus-mediated p53 (rAd-p53) combined with 5-fluorouracil (5-FU) in human colon cancer resistant to 5-FU in vivo and the mechanism of rAd-p53 in reversal of 5-FU resistance. METHODS Nude mice bearing human colon cancer SW480/5FU (5-FU resistant) were randomly assigned to four groups (n = 25 each): control group, 5-FU group, rAd-p53 group, and rAd-p53 + 5-FU group. At 24 h, 48 h, 72 h, 120 h and 168 h after treatment, 5 mice were randomly selected from each group and sacrificed using an overdose of anesthetics. The tumors were removed and the protein expressions of p53, protein kinase C (PKC), permeability-glycoprotein (P-gp) and multidrug resistance-associated protein 1 (MRP1) (Western blot) and apoptosis (TUNEL) were determined. RESULTS The area ratios of tumor cell apoptosis were larger in the rAd/p53 + 5-FU group than that in the control, 5-FU and rAd/p53 groups (P < 0.05), and were larger in the rAd/p53 group than that of the control group (P < 0.05) and the 5-FU group at more than 48 h (P < 0.05). The p53 expression was higher in the rAd/p53 and the rAd/p53 + 5-FU groups than that of the control and 5-FU groups (P < 0.05), and were higher in the rAd/p53 + 5-FU group than that of the rAd/p53 group (P < 0.05). Overexpression of PKC, P-gp and MRP1 was observed in the 5-FU and control groups. In the rAd/p53 + 5-FU group, the expression of P-gp and MRP1 was lower that of the control and 5-FU groups (P < 0.05), and the expression of PKC was lower than that of the control, 5-FU and rAd/p53 groups at more than 48 h (P < 0.05). In the rAd/p53 group, the expression of P-gp and MRP1 was lower that of the control and 5-FU groups at more than 48 h (P < 0.05), and the expression of PKC was lower than that of the control and 5-FU groups at more than 120 h (P < 0.05). CONCLUSION 5-FU combined with rAd-p53 has a synergistic anticancer effect in SW480/5-FU (5-FU resistance), which contributes to reversal 5-FU resistance.
引用
收藏
页码:7342 / 7352
页数:11
相关论文
共 50 条
  • [21] Metformin Inhibited Proliferation and Metastasis of Colorectal Cancer and presented a Synergistic Effect on 5-FU
    Sang, Jing
    Tang, Ruixue
    Yang, Min
    Sun, Qing
    BIOMED RESEARCH INTERNATIONAL, 2020, 2020
  • [22] Combined Manganese Superoxide Dismutase Gene Therapy and 5-FU Chemotherapy for Colorectal Cancer
    Zhang, Yanhong
    He, Lingfeng
    He, Songqing
    Wu, Jian
    Liu, Xinyuan
    MOLECULAR THERAPY, 2006, 13 : S322 - S322
  • [23] Immunohistochemical assessment of p53 and Bcl2 does not predict response to 5-FU for colon cancer patients in the AXIS trial
    Cawkwell, L
    Birbeck, K
    Stenning, S
    Gray, S
    Seymour, M
    Quirke, P
    JOURNAL OF PATHOLOGY, 2000, 192 : 1A - 1A
  • [24] Expression of p53, BclX, and Bak apoptotic regulatory proteins in 5-FU resistant colonic carcinoma hepatic metastases
    Liu, DF
    Fergusson, K
    Mulligan, D
    Cooper, G
    Markowitz, S
    Willis, J
    GASTROENTEROLOGY, 1999, 116 (04) : A455 - A455
  • [25] Heat shock protein 27 is involved in acquisition of 5-FU resistance in human colon cancer
    Tsuruta, Masashi
    Nishibori, Hideki
    Hasegawa, Hirotoshi
    Ishii, Yoshiyuki
    Endo, Takashi
    Nitori, Nobuhiro
    Okabayashi, Koji
    Asahara, Fumitaka
    Kubota, Tetsuro
    Kitajima, Masaki
    CANCER RESEARCH, 2006, 66 (08)
  • [26] Impact of 5-Fu/oxaliplatin on mouse dendritic cells and synergetic effect with a colon cancer vaccine
    Hong, Xinqiang
    Dong, Tiangeng
    Yi, Tuo
    Hu, Jianwei
    Zhang, Zhen
    Lin, Shengli
    Niu, Weixin
    CHINESE JOURNAL OF CANCER RESEARCH, 2018, 30 (02) : 197 - 208
  • [27] Effects and mechanism of juglone in combination with 5-FU on colon cancer CT-26 cells in vivo
    Liu, Tianyu
    Li, Yan
    Li, Na
    2016 INTERNATIONAL CONFERENCE ON MEDICINE SCIENCES AND BIOENGINEERING (ICMSB2016), 2017, 8
  • [28] Impact of 5-Fu/oxaliplatin on mouse dendritic cells and synergetic effect with a colon cancer vaccine
    Xinqiang Hong
    Tiangeng Dong
    Tuo Yi
    Jianwei Hu
    Zhen Zhang
    Shengli Lin
    Weixin Niu
    Chinese Journal of Cancer Research, 2018, 30 (02) : 197 - 208
  • [29] Overexpression of MicroRNA-122 Re-sensitizes 5-FU-Resistant Colon Cancer Cells to 5-FU Through the Inhibition of PKM2 In Vitro and In Vivo
    He, Jinxia
    Xie, Ganfeng
    Tong, Jingtao
    Peng, Yonghai
    Huang, Haihui
    Li, Jianjun
    Wang, Ning
    Liang, Houjie
    CELL BIOCHEMISTRY AND BIOPHYSICS, 2014, 70 (02) : 1343 - 1350
  • [30] Overexpression of MicroRNA-122 Re-sensitizes 5-FU-Resistant Colon Cancer Cells to 5-FU Through the Inhibition of PKM2 In Vitro and In Vivo
    Jinxia He
    Ganfeng Xie
    Jingtao Tong
    Yonghai Peng
    Haihui Huang
    Jianjun Li
    Ning Wang
    Houjie Liang
    Cell Biochemistry and Biophysics, 2014, 70 : 1343 - 1350